Differences

This shows you the differences between two versions of the page.

--- projects:workgroups:kb-wg [2015/01/15 12:23]
rkboyce
+++ projects:workgroups:kb-wg [2017/02/11 17:52]
rkboyce
@@ Line 1: / Line 1: @@
-====== Knowledgebase (LAERTES) Workgroup ======
+====== Pharmacovigilance evidence investigation Workgroup (used to be Knowledge Base / LAERTES)  ======
 <WRAP box justify round>
@@ Line 7: / Line 7: @@
 **Project Lead:**  [[http://ohdsi.org/who-we-are/collaborators/richard-d-boyce-2/|Richard D. Boyce, PhD]]
-**Project Co-Lead:** [[http://ohdsi.org/who-we-are/collaborators/1045-2/|Patrick Ryan, PhD]]
+**Project Co-Lead:** [[http://ohdsi.org/who-we-are/collaborators/erica-voss/|Erica Voss, MPH]]
 **Members:**
-See [[kb-wg#internal|Members List]]
+See [[kb-wg#internal|Members List]] but note that active membership is completely voluntary and open.
 **Start Date:** 6/10/2014
@@ Line 17: / Line 17: @@
 **Repository:**  [[https://github.com/OHDSI/KnowledgeBase]]
-**WG Minutes:** [[https://docs.google.com/document/d/1T3TlmtkCL0BCNMJAUY76h4EV2mapEMAclaRFgmY_zzE/edit?usp=drive_web|Knowledge Base WG Minutes]]
+**WG Minutes:** [[https://docs.google.com/document/d/1T3TlmtkCL0BCNMJAUY76h4EV2mapEMAclaRFgmY_zzE/edit?usp=drive_web|WG Minutes]]
+**WG Agendas:** [[http://forums.ohdsi.org/t/laertes-team-meeting-agenda/172| WG Agendas]]
+**Publications:**
+Boyce. RD., Ryan. PB., Noren. N., et al., Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Safety. 2014. Volume 37, Issue 8 (2014), Page 557-567. DOI: 10.1007/s40264-014-0189-0, PubMed PMID: 24985530. PMCID: PMC4134480. http://link.springer.com/article/10.1007%2Fs40264-014-0189-0
+E.A. Voss, R.D. Boyce, P.B. Ryan, J. van der Lei, P.R. Rijnbeek, M.J. Schuemie, Accuracy of an Automated Knowledge Base for Identifying Drug Adverse Reactions, Journal of Biomedical Informatics, Available online 16 December 2016, ISSN 1532-0464, http://dx.doi.org/10.1016/j.jbi.2016.12.005.
+Boyce, RD., Voss, E., Huser, V., Evans, L., Reich, C., Duke, JD., Tatonetti, NP., Lorberbaum, T., Dumontier, M., Hauben, M., Wallberg, M.,  Peng, L., Dempster, S., He, O., Sena, A., Koutkias, V., Natsiavas, P., Ryan, P. LAERTES: An open system architecture for linking pharmacovigilance evidence sources with clinical data. Journal of Biomedical Semantics. Accepted on 1/3/2017. In Process.
-**WG Agendas:** [[http://forums.ohdsi.org/t/laertes-team-meeting-agenda/172|Knowledge Base WG Agendas]]
 </WRAP>
-==== Meetings ====
+==== Meetings (Telecon Info) ====
-    Schedule: Every other Wednesday at 12 Eastern starting from January 14th 2015
+    Schedule: Once per month schedule:
-    Please join my meeting.
-    https://global.gotomeeting.com/join/530277469
-    You can call in for audio:
-    Dial +1 (646) 749-3122
-    Access Code: 530-277-469
-=== Discussions ===
+Feb - Tues 6th at 3pm Eastern
-[[http://forums.ohdsi.org/t/laertes-api/128|Laertes API]]
-[[http://forums.ohdsi.org/t/laertes-update-of-the-pharmacovigilance-signals/173/1|update of the pharmacovigilance signals]]
+    Please join my meeting.
+    https://global.gotomeeting.com/join/530277469
-[[http://forums.ohdsi.org/t/laertes-pre-load-queries-hoi-from-x-to-snomed-rxnorm-bd-to-cd/180|LAERTES: pre-load queries - hoi from X to snomed, rxnorm BD to CD]]
+    Use your microphone and speakers (VoIP) - a headset is recommended.
+    Or, call in using your telephone:
+    United States: +1 (224) 501-3217
+    Sweden: +46 (0) 853 527 836
+    Access Code: 530-277-469
+=== Discussions ===
-[[http://forums.ohdsi.org/t/laertes-getting-the-pivot-correct-rolling-up-from-clinical-drug-to-ingredient/181|LAERTES: getting the pivot correct - ‘rolling up’ from clinical drug to ingredient]]
+Search for "LAERTES" on [[http://forums.ohdsi.org/]]
 === GitHub Issues ===
-{{ghissues OHDSI/KnowledgeBase state:open}}
+[[https://github.com/OHDSI/KnowledgeBase/issues]]
 === Members List ===
-- Abraham G. Hartzema, PhD, University of Florida, Gainesville, FL
+Richard D. Boyce, University of Pittsburgh, Pittsburgh, PA, rdb20@pitt.edu
+Erica A. Voss, Janssen Research & Development, LLC, Titusville, NJ, EVoss3@its.jnj.com
-- Christian Reich, MD, PhD, AstraZeneca, Waltham MA
+Vojtech Huser, National Institutes of Health, Bethesda, MD, vojtech.huser@nih.gov
-- Christophe Lambert, PhD, University of New Mexico, Albuquerque, NM
+Lee Evans, LTS Computing LLC, West Chester, PA, levans@ltscomputingllc.com
-- Erica A. Voss, MPH, Janssen Research and Development, Titusville, PA
+Christian Reich, QuintilesIMS, Burlington MA, reich@ohdsi.org
-- Gianluca Trifirò, PhD, University of Messina, Messina, Italy & Erasmus University Medical Center, Rotterdam, Netherlands
+Jon D. Duke, Georgia Tech Research Institute, Atlanta, GA, Jon.Duke@gatech.edu
-- J. Marc Overhage, MD, PhD, Siemens Healthcare, Malvern, PA
+Nicholas P. Tatonetti, Herbert Irving Assistant Professor of Biomedical Informatics, Columbia University, New York, NY, nick.tatonetti@columbia.edu
-- Jon Duke, MD, Regenstrief Institute, Indianapolis IN
+Tal Lorberbaum, Columbia University, New York, NY, tal.lorberbaum@columbia.edu
-- Johan Ellenius, PhD, Uppsala Monitoring Centre, Uppsala, Sweden
+Michel Dumontier, Stanford University, Stanford, CA, michel.dumontier@gmail.com
-- Lee Evans, LTS Computing LLC, Exton, PA
+Manfred Hauben, MD. MPH, Pfizer Inc, New York University Medical Center,  New York, NY, manfred.hauben@pfizer.com
-- Majid Rastegar-Mojarad, MS, Mayo Clinic, Rochester, MN
+Magnus Wallberg, Uppsala Monitoring Centre, Uppsala, Sweden, Magnus.Wallberg@who-umc.org
-- Mark Khayter, BS, Ephir, Boston, MA
+Lili Peng, AstraZeneca R&D, Boston , MA, Lili.Peng@astrazeneca.com
-- Martijn J. Schuemie, PhD, Janssen Research and Development, Titusville, PA
+Sara Dempster, AstraZeneca R&D, Boston , MA, sara.dempster@astrazeneca.com
-- Michel Dumontier, PhD, Stanford University, Stanford, CA
+Yongqun He, University of Michigan Medical School, Ann Arbor, Michigan, yongqunh@med.umich.edu
-- Nicholas P. Tatonetti, PhD, Columbia University, New York, NY
+Anthony G. Sena, Janssen Research & Development, LLC, Titusville, NJ, asena5@its.jnj.com
-- Niklas Noren, PhD, Uppsala Monitoring Centre, Uppsala, Sweden
+Vassilis Koutkias, Institute of Applied Biosciences, Center for Research & Technology Hellas, Thermi, Thessaloniki, Greece, vkoutkias@certh.gr
-- Rave Harpaz, PhD, Stanford University, Palo Alto, CA
+Pantelis Natsiavas, Institute of Applied Biosciences, Center for Research & Technology Hellas, Thermi, Thessaloniki, Greece, pnatsiavas@certh.gr
-- Vojtech Huser, MD PhD, National Institutes of Health, Bethesda, MD
+Patrick B. Ryan, Janssen Research & Development, LLC, Titusville, NJ, ryan@ohdsi.org

Observational Health Data Sciences and Informatics

User Tools

Site Tools

Differences

Page Tools